Insys Agrees to $225 Million Settlement of U.S. Claims of Illegal Opioid Sales June 6, 2019 By Jef Feeley and Riley Griffin Insys Therapeutics Inc., grappling with the prospect of bankruptcy after its founder was convicted on racketeering charges, agreed to pay...
Jury Finds Insys Founder, Execs Guilty of Racketeering in Opioid Sales May 3, 2019 By Janelle Lawrence, Riley Griffin and Jef Feeley Insys Therapeutics Inc. founder John Kapoor was convicted of a racketeering conspiracy that drove sales of a highly addictive opioid...
U.S. Charges New York Drug Firm Executives with Opioid Distribution Conspiracy April 24, 2019 By Christian Berthelsen and Jef Feeley Federal prosecutors unveiled the first criminal charges against pharmaceutical executives for illegally diverting opioids, accusing the former chief executive officer...
Opioid Trial Winds Down; Insys Execs Deny Bribing Doctors, Duping Insurers April 5, 2019 By Jef Feeley and Janelle Lawrence A U.S. prosecutor portrayed Insys Therapeutics Inc. founder John Kapoor and other former executives as greedy and heartless during closing...
Jurors Told How Insys Chief Used Competitors’ Data to Drive Own Opioid Sales March 7, 2019 By Janelle Lawrence Insys Therapeutics Inc. founder John Kapoor didn’t cut corners when it came to collecting intelligence on opioid sales, using the...
How High-Pressure Insys Prescription Call Center Lied to Insurers to Sell Opioids February 26, 2019 By Janelle Lawrence The goal for Insys Therapeutics Inc.’s call center in Phoenix was simple: persuade insurers to authorize at least 70 prescriptions...